Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accredited, alongside, anniversary, annum, bank, Barr, beat, bore, buprenorphine, cardiac, compensatory, comprised, conversion, corroborate, crossover, Deferral, Dr, duly, electrical, electrocardiogram, exceeded, Exhibit, fatal, GlaxoSmithKine, heart, hereof, Instance, irrespective, Johnson, Linkbase, LLP, manufac, methodology, Metropolitan, moxifloxacin, nonrefundable, omitted, OUM, page, penny, placebo, plasma, point, prepayment, QTc, QTcB, QTcF, QTcI, rata, ratifying, reclassified, repolarization, repolarize, respond, retailer, rolled, Schema, settle, signature, slope, statutory, substitute, substitution, supplementary, surface, surrender, Taxonomy, thereunto, therewith, tQT, tured, undersigned, upper, Valeant, virtue, Warrant, weak, wide, XBRL
Removed:
abuse, acid, actively, addiction, amortized, Analog, anesthetic, annually, APIC, APPA, apply, arm, average, billion, bupivacaine, calculating, chain, chronic, circulation, commonly, comparability, comparison, considerable, consisting, consolidated, controlling, coupling, Depomed, depression, derivative, diminish, discretion, disorientation, duration, ease, entitle, ester, excellent, exchanged, exercisability, extensively, fell, flexible, flow, forma, formed, fourth, GlaxoSmithKline, hernia, iii, improve, inguinal, intensity, knowledge, Macau, municipal, negatively, Neutrogena, notified, Notwithstanding, nucleic, Ohio, organic, painful, partnering, pill, plain, pledge, poison, pool, portfolio, powerful, privately, promising, prospectively, protected, ranged, redeemable, redeemed, refrigeration, regained, repair, reproducible, respiratory, score, sedation, sensitive, setting, short, Similarly, simplified, stored, systemic, systemically, tangible, transition, undesirable, undisclosed, urinary, vanilla, variant, VAS, vehicle, Visual
Filing tables
Filing exhibits
- 10-K Annual report
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-15(E)
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-15(E)
- 32 Certification of Chief Executive Officer and Chief Financial Officer
Related press release
HRTX similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (Nos. 333-162968 and 333-167890) and the Registration Statements on Form S-8 (Nos. 333-06841, 333-35151, 333-60585, 333-90428, 333-118546, 333-127574, 333-137954, 333-148660, 333-152862, 333-162610, 333-167515, 333-176365 and 333-176366) of our report dated March 23, 2012 with respect to the financial statements and schedule of A.P. Pharma, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2011.
/s/ OUM & CO. LLP |
San Francisco, California |
March 23, 2012 |